Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=53870688&newsitemid=20231214617151&lan=en-US&anchor=Parse+Biosciences&index=1&md5=b97e5c2d22556b5b3691f5a380eabd8e), a leading provider of accessible and scalable single cell sequencing solutions, today announced it has closed a total of $50 million in financing from a Series C equity raise and the closing of a debt facility. Soleus Capital led the Series C equity financing, wh…